Neuropathic Pain Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Neuropathic Pain Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuropathic Pain Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuropathic Pain Drugs Overall Market Size
2.1 Global Neuropathic Pain Drugs Market Size: 2021 VS 2027
2.2 Global Neuropathic Pain Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuropathic Pain Drugs Players in Global Market
3.2 Top Global Neuropathic Pain Drugs Companies Ranked by Revenue
3.3 Global Neuropathic Pain Drugs Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Pain Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Neuropathic Pain Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Pain Drugs Players in Global Market
3.6.1 List of Global Tier 1 Neuropathic Pain Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Pain Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuropathic Pain Drugs Market Size Markets, 2021 & 2027
4.1.2 Tricyclic Anti-Depressants Anticonvulsants
4.1.3 Serotonin-Norepinephrine Reuptake Inhibitor
4.1.4 Capsaicin Cream
4.1.5 Local Anaesthesia
4.1.6 Opioids
4.1.7 Steroids
4.1.8 Others
4.2 By Type - Global Neuropathic Pain Drugs Revenue & Forecasts
4.2.1 By Type - Global Neuropathic Pain Drugs Revenue, 2016-2021
4.2.2 By Type - Global Neuropathic Pain Drugs Revenue, 2022-2027
4.2.3 By Type - Global Neuropathic Pain Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuropathic Pain Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Neuropathic Pain Drugs Revenue & Forecasts
5.2.1 By Application - Global Neuropathic Pain Drugs Revenue, 2016-2021
5.2.2 By Application - Global Neuropathic Pain Drugs Revenue, 2022-2027
5.2.3 By Application - Global Neuropathic Pain Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Neuropathic Pain Drugs Market Size, 2021 & 2027
6.2 By Region - Global Neuropathic Pain Drugs Revenue & Forecasts
6.2.1 By Region - Global Neuropathic Pain Drugs Revenue, 2016-2021
6.2.2 By Region - Global Neuropathic Pain Drugs Revenue, 2022-2027
6.2.3 By Region - Global Neuropathic Pain Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Neuropathic Pain Drugs Revenue, 2016-2027
6.3.2 US Neuropathic Pain Drugs Market Size, 2016-2027
6.3.3 Canada Neuropathic Pain Drugs Market Size, 2016-2027
6.3.4 Mexico Neuropathic Pain Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Neuropathic Pain Drugs Revenue, 2016-2027
6.4.2 Germany Neuropathic Pain Drugs Market Size, 2016-2027
6.4.3 France Neuropathic Pain Drugs Market Size, 2016-2027
6.4.4 U.K. Neuropathic Pain Drugs Market Size, 2016-2027
6.4.5 Italy Neuropathic Pain Drugs Market Size, 2016-2027
6.4.6 Russia Neuropathic Pain Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Neuropathic Pain Drugs Market Size, 2016-2027
6.4.8 Benelux Neuropathic Pain Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Neuropathic Pain Drugs Revenue, 2016-2027
6.5.2 China Neuropathic Pain Drugs Market Size, 2016-2027
6.5.3 Japan Neuropathic Pain Drugs Market Size, 2016-2027
6.5.4 South Korea Neuropathic Pain Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Neuropathic Pain Drugs Market Size, 2016-2027
6.5.6 India Neuropathic Pain Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Neuropathic Pain Drugs Revenue, 2016-2027
6.6.2 Brazil Neuropathic Pain Drugs Market Size, 2016-2027
6.6.3 Argentina Neuropathic Pain Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuropathic Pain Drugs Revenue, 2016-2027
6.7.2 Turkey Neuropathic Pain Drugs Market Size, 2016-2027
6.7.3 Israel Neuropathic Pain Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Neuropathic Pain Drugs Market Size, 2016-2027
6.7.5 UAE Neuropathic Pain Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neuropathic Pain Drugs Major Product Offerings
7.1.4 Pfizer Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Neuropathic Pain Drugs Major Product Offerings
7.2.4 Johnson & Johnson Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.2.5 Johnson & Johnson Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Neuropathic Pain Drugs Major Product Offerings
7.3.4 Sanofi Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Neuropathic Pain Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Neuropathic Pain Drugs Major Product Offerings
7.5.4 Eli Lilly Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.5.5 Eli Lilly Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Key News
7.7 Biogen
7.7.1 Biogen Corporate Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Neuropathic Pain Drugs Major Product Offerings
7.4.4 Biogen Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.7.5 Biogen Key News
7.8 Baxter Healthcare
7.8.1 Baxter Healthcare Corporate Summary
7.8.2 Baxter Healthcare Business Overview
7.8.3 Baxter Healthcare Neuropathic Pain Drugs Major Product Offerings
7.8.4 Baxter Healthcare Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.8.5 Baxter Healthcare Key News
7.9 Depomed
7.9.1 Depomed Corporate Summary
7.9.2 Depomed Business Overview
7.9.3 Depomed Neuropathic Pain Drugs Major Product Offerings
7.9.4 Depomed Neuropathic Pain Drugs Revenue in Global (2016-2021)
7.9.5 Depomed Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Neuropathic Pain Drugs Market Opportunities & Trends in Global Market
Table 2. Neuropathic Pain Drugs Market Drivers in Global Market
Table 3. Neuropathic Pain Drugs Market Restraints in Global Market
Table 4. Key Players of Neuropathic Pain Drugs in Global Market
Table 5. Top Neuropathic Pain Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Neuropathic Pain Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Neuropathic Pain Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Neuropathic Pain Drugs Product Type
Table 9. List of Global Tier 1 Neuropathic Pain Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuropathic Pain Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Neuropathic Pain Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Neuropathic Pain Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Neuropathic Pain Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Neuropathic Pain Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Neuropathic Pain Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Neuropathic Pain Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Neuropathic Pain Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Neuropathic Pain Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Neuropathic Pain Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Neuropathic Pain Drugs Product Offerings
Table 32. Pfizer Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Neuropathic Pain Drugs Product Offerings
Table 35. Johnson & Johnson Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Neuropathic Pain Drugs Product Offerings
Table 38. Sanofi Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Neuropathic Pain Drugs Product Offerings
Table 41. GlaxoSmithKline Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Neuropathic Pain Drugs Product Offerings
Table 44. Eli Lilly Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Neuropathic Pain Drugs Product Offerings
Table 47. Bristol-Myers Squibb Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Biogen Corporate Summary
Table 49. Biogen Neuropathic Pain Drugs Product Offerings
Table 50. Biogen Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Baxter Healthcare Corporate Summary
Table 52. Baxter Healthcare Neuropathic Pain Drugs Product Offerings
Table 53. Baxter Healthcare Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Depomed Corporate Summary
Table 55. Depomed Neuropathic Pain Drugs Product Offerings
Table 56. Depomed Neuropathic Pain Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Neuropathic Pain Drugs Segment by Type
Figure 2. Neuropathic Pain Drugs Segment by Application
Figure 3. Global Neuropathic Pain Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Neuropathic Pain Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Neuropathic Pain Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuropathic Pain Drugs Revenue in 2020
Figure 8. By Type - Global Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 12. US Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 24. China Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Neuropathic Pain Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Neuropathic Pain Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanofi Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GlaxoSmithKline Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bristol-Myers Squibb Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Biogen Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Baxter Healthcare Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Depomed Neuropathic Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed